Chemical probes of UDP-galactopyranose mutase

被引:108
作者
Carlson, Erin E.
May, John F.
Kiessling, Laura L. [1 ]
机构
[1] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA
[2] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA
来源
CHEMISTRY & BIOLOGY | 2006年 / 13卷 / 08期
关键词
D O I
10.1016/j.chembiol.2006.06.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Many pathogenic prokaryotes and eukaryotes possess the machinery required to assemble galactofuranose (Galf-containing glycoconjugates; these glycoconjugates can be critical for virulence or viability. Accordingly, compounds that block Galf incorporation may serve as therapeutic leads or as probes of the function of Galf-containing glycoconjugates. The enzyme UDP-galactopyranose mutase (UGM) is the only known generator of UDP-galactofuranose, the precursor to Galf residues. We previously employed a high-throughput fluorescence polarization assay to investigate the Klebsiella pneumoniae UGM. We demonstrate the generality of this assay by extending it to UGM from Mycobacterium tuberculosis. To identify factors influencing binding, we synthesized a directed library containing a 5-arylidene-2-thioxo-4-thiazolidinone core, a structure possessing features common to ligands for both homologs. Our studies offer a blueprint for identifying inhibitors of the growing family of UGM homologs and provide insight into UGM inhibition.
引用
收藏
页码:825 / 837
页数:13
相关论文
共 92 条
  • [1] STRUCTURE OF THE O-ANTIGEN POLYSACCHARIDE OF HEMOPHILUS-PLEUROPNEUMONIAE SEROTYPE-3 (ATCC-27090) LIPOPOLYSACCHARIDE
    ALTMAN, E
    BRISSON, JR
    PERRY, MB
    [J]. CARBOHYDRATE RESEARCH, 1988, 179 : 245 - 258
  • [2] 4-thiazolidinones: Novel inhibitors of the bacterial enzyme MurB
    Andres, CJ
    Bronson, JJ
    D'Andrea, SV
    Deshpande, MS
    Falk, PJ
    Grant-Young, KA
    Harte, WE
    Ho, HT
    Misco, PF
    Robertson, JG
    Stock, D
    Sun, YX
    Walsh, AW
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (08) : 715 - 717
  • [3] Genome-wide RNAi analysis of Caenorhabditis elegans fat regulatory genes
    Ashrafi, K
    Chang, FY
    Watts, JL
    Fraser, AG
    Kamath, RS
    Ahringer, J
    Ruvkun, G
    [J]. NATURE, 2003, 421 (6920) : 268 - 272
  • [4] Halogen bonds in biological molecules
    Auffinger, P
    Hays, FA
    Westhof, E
    Ho, PS
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (48) : 16789 - 16794
  • [5] SYNTHESIS SUBSTITUITED RHODANINE
    AUGUSTIN, M
    RUDORF, WD
    [J]. JOURNAL FUR PRAKTISCHE CHEMIE, 1974, 316 (03): : 520 - 524
  • [6] Identification and partial characterization of two eukaryotic UDP-galactopyranose mutases
    Bakker, H
    Kleczka, B
    Gerardy-Schahn, R
    Routier, FH
    [J]. BIOLOGICAL CHEMISTRY, 2005, 386 (07) : 657 - 661
  • [7] CARBOHYDRATE STRUCTURES OF 3 NOVEL PHOSPHOINOSITOL-CONTAINING SPHINGOLIPIDS FROM THE YEAST HISTOPLASMA-CAPSULATUM
    BARR, K
    LAINE, RA
    LESTER, RL
    [J]. BIOCHEMISTRY, 1984, 23 (23) : 5589 - 5596
  • [8] New horizons in the treatment of tuberculosis
    Barry, CE
    [J]. BIOCHEMICAL PHARMACOLOGY, 1997, 54 (11) : 1165 - 1172
  • [9] Crystal structures of Mycobacteria tuberculosis and Klebsiella pneumoniae UDP-galactopyranose mutase in the oxidised state and Klebsiella pneumoniae UDP-galactopyranose mutase in the (Active) reduced state
    Beis, K
    Srikannathasan, V
    Liu, H
    Fullerton, SWB
    Bamford, VA
    Sanders, DAR
    Whitfield, C
    McNeil, MR
    Naismith, JH
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2005, 348 (04) : 971 - 982
  • [10] The mycobacterial cell envelope: A target for novel drugs against tuberculosis
    Besra, GS
    Brennan, PJ
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1997, 49 : 25 - 30